Viewing Study NCT02913261


Ignite Creation Date: 2025-12-24 @ 12:44 PM
Ignite Modification Date: 2026-01-14 @ 9:45 AM
Study NCT ID: NCT02913261
Status: COMPLETED
Last Update Posted: 2023-02-08
First Post: 2016-09-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation
Sponsor:
Organization: